A biomarker panel for risk of early respiratory failure following hematopoietic cell transplantation

A biomarker panel for risk of early respiratory failure following hematopoietic cell transplantation

Plasma biomarkers associated with respiratory failure (RF) following hematopoietic cell transplantation (HCT) have not been identified. Therefore, we aimed to validate early (7 and 14 days post-HCT) risk biomarkers for RF. Using tandem mass spectrometry, we compared plasma obtained at day 14 post-HC...

Full description

Bibliographic Details
Main Authors: Bollard, C.M (Author), Carpenter, P.A (Author), Cooke, K.R (Author), Cruz, C.R.Y (Author), Duncan, C.N (Author), Farag, S. (Author), Gafken, P.R (Author), Jacobsohn, D. (Author), Krance, R.A (Author), Kudchadkar, S. (Author), Little, M.R (Author), Loftis, L. (Author), Malatpure, A. (Author), Paczesny, S. (Author), Pike, F. (Author), Renbarger, J. (Author), Rowan, C.M (Author), Sharron, M.P (Author), Smith, L. (Author)
Format: Article
Language:English
Published: American Society of Hematology 2022
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items